Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
With the vaccine rollout going slowly, experts debate delaying second dose.
The technology used in COVID-19 vaccines may also be used to prevent many viral infections and treat cancer and multiple sclerosis.
The ACTIV-2 study aims to determine whether neutralizing antibodies reduce the duration of COVID-19 symptoms.
Scientists fear another virus will leap from wildlife into humans, one that is far more lethal but spreads as easily as SARS-CoV-2.
Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness.
People who have had evidence of a prior infection appear to have some degree of protection against being reinfected with the virus.
American hubris prevented the country from reacting as quickly and effectively as Asian nations.
Preliminary results suggest anti-COVID19 nanobodies may be effective at preventing and diagnosing infections.
Anthony Fauci, President-elect Joe Biden and senior legislators were vaccinated publicly to demonstrate their confidence in vaccine safety.
The feat facing public health officials has absolutely no comparison in recent history.
Among 64 pregnant women who tested positive for SARS-CoV-2, none of their newborns tested positive.
Two Phase III clinical trials are evaluating monoclonal antibodies for people hospitalized with moderate COVID-19.
In Los Angeles County, daily new COVID cases, deaths and hospitalizations have soared beyond their previous highs.
People with HIV, people with cancer and pregnant people can be vaccinated against the coronavirus.
The study will evaluate short- and long-term health outcomes of COVID-19, including multisystem inflammatory syndrome.
Moderna’s coronavirus vaccine is 94% effective in preventing symptomatic COVID-19—and it may also reduce asymptomatic infection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.